Objective:To investigate the effect of budesonide combined with terbutaline inhalation on mycoplasma pneumonia (MPP) and pulmonary function in children. Methods:One hundred and eighty patients were selected as study subjects. All the patients were randomly divided into control group and observation group with 90 cases in each group. The control group received routine therapy, while the observation group received treatment of budesonide combined with terbutaline inhalation in addition to routine therapy. The therapeutic effect, time of clinical symptom improvement, forced vital capacity (FVC), peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV1) were observed and documented in the two groups. Results:The effective rate (91.1%) in the observation group was significantly higher than that (78.9%) in the control group (P<0.05). The time of defervescence, disappearance of cough, asthma and moist rales in the observation group was obviously less than that in the control group (P<0.05). The FVC, PEF and FEV1 were improved both in the control group and the observation group 10 days after treatment. The pulmonary function of observation group was significantly better than that of the control group (P<0.05). Conclusion:Budesonide combined with terbutaline inhalation can improve curative rate, clinical symptoms and pulmonary function in the treatment of children with MPP. |
[1] 胡静,胡克坤.布地奈德雾化吸入对肺炎支原体肺炎患儿肺功能及体液免疫功能的影响[J].安徽医学,2017,38(6):730-732.
[2] 杜晓宁,梁丽霞,严慧芳,等.阿奇霉素序贯疗法联合特步他林治疗小儿支原体肺炎的临床观察[J].中国药房,2016,27(6):740-742.
[3] 赵小芳,郦建娣,骆波.孟鲁司特钠与特布他林联合治疗儿童咳嗽变异性哮喘临床疗效分析[J].中华医院感染学杂志,2014,24(22):5678-5680.
[4] 王卫平.儿科学.8版[M].北京:人民卫生出版社,2013:284-286.
[5] OLSON D,WATKINS L K,DEMIRJIAN A,et al.Outbreak of mycoplasma pneumoniae-associated stevens-johnson syndrome[J].Pediatrics,2015,136(2):386-394.
[6] ISHIGURO N,KOSEKI N,KAIHO M,et al.Sensitivity and Specificity of a loop-mediated isothermal amplification assay for the detection of mycoplasma pneumonia from nasopharyngeal swab samples compared with those of real-time PCR[J].Clinical Laboratory,2015,61(5-6):603-606.
[7] NRISINGH Y S,KUMAR G M,LI J.肺炎支原体感染与儿童哮喘的相关性[J].东南大学学报(医学版),2015,34(2):280-285.
[8] 周朋,周旭,张葆青.儿童难治性支原体肺炎发病机制研究进展[J].山东医药,2016,56(42):103-105.
[9] 吴玉丽,赵晓莉,王游.阿奇霉素、β2受体兴奋剂联合糖皮质激素吸入治疗支原体感染引发小儿哮喘的临床效果研究[J].临床和实验医学杂志,2016,15(19):1880-1883.
[10] 李红霞.布地奈德与特布他林联合雾化吸入治疗儿童支气管哮喘急性发作的疗效观察[J].中国医院用药评价与分析,2016,16(4):451-453.
[11] 邹艳萍,罗小兰,刘利.布地奈德与丙酸倍氯米松辅助特布他林雾化吸入治疗小儿哮喘急性发作的对比研究[J].中国药房,2016,27(17):2388-2391.
[12] 林忠响.雾化吸入特布他林和布地奈德联合服用小儿咳喘灵颗粒治疗小儿哮喘的临床效果研究[J].中国基层医药,2017,24(5):710-713.
[13] SIMPSON A J,BOOD J R,ANDERSON S D,et al.A standard,single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes[J].J Appl Physiol,2016,120(9):1011-1017.
[14] 吕璟,王庆丰.布地奈德联合特布他林雾化吸入治疗哮喘急性发作的疗效观察[J].中国基层医药,2017,24(10):1567-1570.
[15] 杜占申.布地奈德联合特布他林雾化吸人治疗小儿支气管肺炎的疗效观察[J].现代预防医学,2011,38(17):3464-3465. |